Tweet Here you can find Will's latest speeches and appearances in Parliament (provided by theyworkforyou):
Blood Cancer: Research | Department of Health and Social Care | Written Answers As with other Government funders of health research, the National Institute for Health and Care Research (NIHR) does not allocate funding
Cannabis: Medical Treatments | Department of Health and Social Care | Written Answers Licensed cannabis-based medicines are routinely available on the National Health Service.
Drugs: Patients | Department of Health and Social Care | Written Answers The Department has no role in the costs of medicines purchased in the private sector.
Voluntary Scheme for Branded Medicines Pricing and Access | Department of Health and Social Care | Written Answers I met with the Association of the British Pharmaceutical Industry and other relevant trade associations in advance of negotiations for th
Fractures: Osteoporosis | Department of Health and Social Care | Written Answers I refer the Rt hon. Member to the answer I gave on 18 July 2023 to Question 192563.
Dementia: Diagnosis | Department of Health and Social Care | Written Answers Join Dementia Research (JDR), delivered by the Department via the National Institute for Health and Care Research (NIHR) and in partnersh
Hormone Replacement Therapy: Shortages | Department of Health and Social Care | Written Answers There are over 70 hormone replacement therapy (HRT) products, and the vast majority are in good supply.
Mental Health: Disclosure of Information | Department of Health and Social Care | Written Answers Mental Health is one of the six groups of conditions that are within the scope of the forthcoming Major Conditions Strategy (MCS).
Heart Diseases: Diagnosis | Department of Health and Social Care | Written Answers We have heard from a wide range of stakeholders, and their views are informing the development of the Major Conditions Strategy (MCS).
Cancer: Children and Young People | Department of Health and Social Care | Written Answers The Government has taken steps to improve the delivery of clinical trials in the United Kingdom, including those researching preventative